Skip to search
Skip to main content
Skip to first result
Harold Varmus - Profiles in Science
Contact
About
Harold Varmus
The Harold Varmus Papers
Home
The Story
Biographical Overview
Retroviruses and the Genetic Origins of Cancer, 1970-1993
AIDS and HIV: Science, Politics, and Controversy, 1981-1993
Basic Science and Congressional Politics: NIH Director, 1993-1999
Memorial Sloan Kettering Cancer Center, 2000-2010, and National Cancer Institute, 2010-2015
Additional Resources
Glossary
Collection Items
search for
Search
Search
Home
Search results
Search
« Previous |
1
-
100
of
360
|
Next »
Sort
by Relevance
Relevance
Title (A-Z)
Title (Z-A)
Date (oldest to newest)
Date (newest to oldest)
Number of results to display per page
100
per page
per page
10
per page
20
per page
50
per page
100
per page
View results as:
List
List
Gallery
Gallery
Masonry
Masonry
Slideshow
Slideshow
Search Results
×
[Revertant DNA data] (image 2)
1 of 360
[Revertant DNA data] (gel 1)
2 of 360
[Revertant DNA data] (gel 2)
3 of 360
[Revertant DNA data] (gel 3)
4 of 360
[Revertant DNA data] (image 3)
5 of 360
Varieties of RNA Tumor Virus-Specific DNA in Cells
6 of 360
Genetic Functions of Avian Sarcoma Viruses
7 of 360
1982 Award Winner - Harold E. Varmus
8 of 360
Harold Varmus receiving Montgomery County bicyclist of the year award from county officials
9 of 360
Lasker Award Winners, 1982
10 of 360
Harold Varmus speaking at lectern
11 of 360
Harold Varmus at his desk
12 of 360
Harold Varmus
13 of 360
Harold Varmus
14 of 360
UCSF's Nobels: Surprise, Satisfaction and the World Reaction . . .
15 of 360
Harold Varmus
16 of 360
Some General Comments on Cloning and the Use of the P2 Room
17 of 360
Letter from Harold Varmus to Ian Macpherson, Imperial Cancer Research Fund Laboratories
18 of 360
Letter from Harold Varmus to F. Kisseljou, D. I. Ivanovsky Virology Institute
19 of 360
Memorandum of Understanding and Agreement: Recombinant DNA
20 of 360
Report from Cold Spring Harbor, 1979: Viral Oncogenes (and Other Items)
21 of 360
Excerpt from Varmus' notebook from the Gordon Conference on Animal Cells and Viruses
22 of 360
Notes from science writers seminar
23 of 360
Rous RNA 5/11
24 of 360
RNA Tumor Viruses
25 of 360
Letter from Harold Varmus to David W. Kingsbury, Sir William Dunn School of Pathology, University of Oxford
26 of 360
Letter from David W. Kingsbury, Sir William Dunn School of Pathology, University of Oxford to Harold Varmus
27 of 360
Letter from Harold Varmus to Natalie Teich, Imperial Cancer Research Fund Laboratories
28 of 360
Letter from Erling Norrby, Department of Virology, Karolinska Institute to Harold Varmus
29 of 360
Letter from Harold Varmus to David W. Kingsbury, St. Jude Children's Research Hospital
30 of 360
Letter from Natalie Teich, Imperial Cancer Research Fund Laboratories to Harold Varmus
31 of 360
Letter from David W. Kingsbury, St. Jude Children's Research Hospital to Harold Varmus
32 of 360
Letter from Robin A. Weiss, Institute of Cancer Research to Harold Varmus
33 of 360
Letter from James D. Watson, Cold Spring Harbor Laboratory to Harold Varmus
34 of 360
Memorandum from Robert J. Huebner, National Institutes of Health to Harold Varmus [regarding Varmus' manuscript on the detection of new and additional virus-specific DNA sequences in chick embryo fibroblasts after infection by RSV]
35 of 360
Letter from Alexandra M. Levine, University of Southern California Comprehensive Cancer Center to Harold Varmus
36 of 360
Letter from David B. McEwan, Honolulu Medical Group, Inc. to Harold Varmus
37 of 360
Letter from W. Abe Andes, Tulane University Medical Center to Harold Varmus
38 of 360
Letter from Hilary Wass to Harold Varmus
39 of 360
Letter from Harold Varmus to Luis M. de la Maza, University of Minnesota
40 of 360
Bishop, Varmus Become UCSF's First Nobel Prize Winners
41 of 360
Is Cancer Part of Our Genetic Dowry? Proto-Oncogenes May Be Cancer Switches
42 of 360
The Hunting of the src and "Jumping Genes"
43 of 360
Squirrels Have It
44 of 360
Letter from Paul Neiman, Providence Hospital to Harold Varmus
45 of 360
Notes on Genetic Engineering Seminar
46 of 360
Viral Replication and Genetics
47 of 360
Letter from Harold Varmus to Max Essex, Harvard School of Public Health
48 of 360
Letter from Natalie Teich, Imperial Cancer Research Fund Laboratories to Harold Varmus
49 of 360
Letter from John M. Coffin, Tufts University School of Medicine to Harold Varmus
50 of 360
Letter from Robin A. Weiss, Institute of Cancer Research to Harold Varmus
51 of 360
Letter from Max Essex, Harvard School of Public Health to Harold Varmus
52 of 360
Letter from Jay A. Levy, University of California, San Francisco School of Medicine to Harold Varmus
53 of 360
Letter from Joseph L. Melnick, Baylor College of Medicine to Harold Varmus
54 of 360
Nucleotide Sequences Related to the Transforming Gene of Avian Sarcoma Virus are Present in DNA of Uninfected Vertebrates
55 of 360
Integration of Deoxyribonucleic Acid Specific for Rous Sarcoma Virus after Infection of Permissive and Nonpermissive Hosts
56 of 360
Letter from William A. Haseltine, Dana-Farber Cancer Institute to Harold Varmus
57 of 360
Letter from Peter Bentvelzen, Radiobiological Institute of the Organization for Health Research (The Netherlands) to Harold Varmus
58 of 360
Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [on the initial call for proposals on the nomenclature of the AIDS virus]
59 of 360
Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [with the initial set of proposals on the nomenclature of the AIDS virus]
60 of 360
Letter from Jay A. Levy, University of California, San Francisco School of Medicine to Harold Varmus
61 of 360
Letter from Jay A. Levy, University of California, San Francisco School of Medicine to Harold Varmus
62 of 360
Letter from Ashley T. Haase, University of Minnesota Medical School to Harold Varmus
63 of 360
Letter from Harold Varmus to fellow clinicians who work with AIDS patients on their suggestions for naming the AIDS virus
64 of 360
Letter from Renato Dulbecco, Salk Institute to Harold Varmus
65 of 360
Excerpt from UCSF School of Medicine's Department of Biochemistry and Biophysics' 1992-1993 Annual Report
66 of 360
Letter from Andre Lwoff, Institut Pasteur (France) to Harold Varmus [Transcription]
67 of 360
Letter from Andre Lwoff, Institut Pasteur (France) to Harold Varmus
68 of 360
Varmus's testimony before the Subcommittee on Health and Environment, Committee on Commerce, U.S. House of Representatives
69 of 360
Transcript of Varmus's testimony at Congressional Hearing "Biotechnology and the Ethics of Cloning: How Far Should We Go?"
70 of 360
Varmus Portrait Dedicated in Bldg. 1
71 of 360
Letter from Harold Varmus to Salvador E. Luria
72 of 360
Report of the 3rd International Congress of Virology
73 of 360
Tumor Viruses and Oncogenes
74 of 360
Letter from Harold Varmus to Michael I. Goldberg
75 of 360
Statement of Harold Varmus, MD, Director, National Institutes of Health, before the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies
76 of 360
Hearing of the Labor, Health and Human Services, and Education Subcommittee of the Senate Appropriations Committee. Subject: Embryonic Stem Cell Research [Transcript]
77 of 360
Statement of Harold Varmus, MD, Director, National Institutes of Health, before the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies
78 of 360
Letter from U.S. Congressman Jay Dickey, et al. to Donna E. Shalala
79 of 360
Letter from Donna E. Shalala to U.S. Representative Jay Dickey
80 of 360
Letter from Charles Yanofsky to Donald S. Fredrickson, National Institutes of Health
81 of 360
Memorandum from Harriet Rabb to Harold Varmus [on federal funding for research involving human pluripotent stem cells]
82 of 360
Presidential Bioethics Advisors May Well Come Down on the Side of Federal Funding for Research on Stem Cells Derived from Embryos
83 of 360
Fact Sheet on Stem Cell Research
84 of 360
For the ICRF Annual Report, 1979: II. Retroviruses as Mutagens: Isolation of Revertants with Deletions and/or Insertions in the ASV Provirus in B31 Cells after Superinfection with MuLV
85 of 360
For the ICRF Annual Report, 1979: I. The Rare Revertants of an ASV-Transformed Rat Cell Have Lost Proviral DNA or Bear Mutations in SRC
86 of 360
For the ICRF Annual Report, 1979: III. Co-Transfection with Papovavirus and Retrovirus DNA Using Recombinant DNA Prepared In vitro
87 of 360
Letter from Harold Varmus to Howard Young, National Cancer Institute
88 of 360
Letter from Harold Varmus to Inder M. Verma, Imperial Cancer Research Fund Laboratories
89 of 360
Memorandum from Harold Varmus to Keith Hadley, Campus Biosafety Committee, University of California, San Francisco
90 of 360
Letter from Harold Varmus to Donald S. Fredrickson, National Institutes of Health
91 of 360
Letter from Harold Varmus to T. Ando, Institute of Physical and Chemical Research (Japan)
92 of 360
Letter from Harold Varmus to David Baltimore, Institute of Cancer Research
93 of 360
Letter from Harold Varmus to John Z. Bowers, Josiah Macy, Jr. Foundation
94 of 360
Using Recombinant DNA Technology to Study the Behavior of Retroviruses
95 of 360
Research proposal to the American Business Cancer Research Foundation
96 of 360
Letter from J. Michael Bishop and Harold Varmus to Harry D. Williams II, American Business Cancer Research Foundation
97 of 360
Letter from Harold Varmus to James D. Watson, Cold Spring Harbor Laboratory
98 of 360
Letter from Mike Fried, Imperial Cancer Research Fund Laboratories to Harold Varmus
99 of 360
Letter from Harold Varmus to Marilyn Kozak, University of Pittsburgh
100 of 360
previous image
next image
Pause Slideshow
Start Slideshow
« Previous
Next »
1
2
3
4